Skip to content
Trial Eligibility
Menu

Daily Amino Acid Supplementation for People With Parkinson's Disease

NCT07115563

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid supplement increase essential amino acids (nutritional status)? Does the tailored amino acid supplement increase an antioxidant (complex amino acid) and decrease an amino acid associated with oxidative stress?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Parkinson Disease (PD)

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
50 to 90 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Cristina Colon-Semenza
Last updated on ClinicalTrials.gov
August 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Connecticut · 2

  • UConn Health · Farmington, CT
  • University of Connecticut · Storrs, CT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.